Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · IEX Real-Time Price · USD
0.845
-0.046 (-5.11%)
Aug 19, 2022 3:04 PM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Selling, General & Admin
|
13.55 | 14.93 | 8.59 | 2.29 | 2.46 |
| Research & Development
|
23.9 | 37.88 | 20.95 | 14.19 | 13.39 |
| Operating Expenses
|
37.45 | 52.81 | 29.54 | 16.49 | 15.85 |
| Operating Income
|
-37.45 | -52.81 | -29.54 | -16.49 | -15.85 |
| Interest Expense / Income
|
-0 | -0.22 | -0.16 | 0 | 0 |
| Other Expense / Income
|
-0.32 | 0.89 | -1.33 | -0.96 | -0.66 |
| Pretax Income
|
-37.13 | -53.48 | -28.06 | -15.53 | -15.19 |
| Net Income
|
-37.13 | -53.48 | -28.06 | -15.53 | -15.19 |
| Net Income Common
|
-37.13 | -53.48 | -28.06 | -15.53 | -15.19 |
| Shares Outstanding (Basic)
|
21 | 21 | 6 | 1 | 1 |
| Shares Outstanding (Diluted)
|
21 | 21 | 6 | 1 | 1 |
| Shares Change
|
0.72% | 252.08% | 419.98% | 0.11% | - |
| EPS (Basic)
|
-1.74 | -2.53 | -4.67 | -13.45 | -13.17 |
| EPS (Diluted)
|
-1.74 | -2.53 | -4.67 | -13.45 | -13.17 |
| Free Cash Flow Per Share
|
-1.77 | -1.98 | -4.46 | -13.21 | -12.14 |
| EBITDA
|
-36.86 | -53.47 | -28.05 | -15.52 | -15.18 |
| Depreciation & Amortization
|
0.27 | 0.23 | 0.17 | 0.01 | 0.01 |
| EBIT
|
-37.13 | -53.7 | -28.22 | -15.53 | -15.19 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).